ERBB2 and breast carcinoma: Gallen International Breast Cancer Conference 2013, a novel surrogate intrinsic subtype of breast cancer was suggested to distinguish luminal A, luminal B (HER2−/HER2+), HER2 enriched, and triple-negative disease.